Shoker Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$612K Hold
665
0.18% 69
2025
Q4
$715K Buy
665
+5
+0.8% +$4.78K 0.21% 62
2025
Q3
$504K Sell
660
-6
-0.9% -$4.46K 0.15% 75
2025
Q2
$520K Hold
666
0.16% 74
2025
Q1
$551K Hold
666
0.19% 68
2024
Q4
$515K Sell
666
-13
-2% -$10.8K 0.17% 69
2024
Q3
$602K Buy
679
+13
+2% +$11.7K 0.2% 66
2024
Q2
$603K Sell
666
-74
-10% -$59.2K 0.21% 65
2024
Q1
$563K Buy
740
+174
+31% +$124K 0.2% 68
2023
Q4
$330K Buy
566
+139
+33% +$81.1K 0.13% 73
2023
Q3
$229K Hold
427
0.1% 82
2023
Q2
$200K Buy
+427
New +$179K 0.08% 88
2020
Q3
Sell
-1,326
Closed -$217K 89
2020
Q2
$217K Buy
+1,326
New +$204K 0.15% 78

Other funds holding LLY

Shoker Investment Counsel's LLY Position: Q1 2026 in Review

Shoker Investment Counsel held its Eli Lilly (LLY) position steady in Q1 2026 at 665 shares worth $612K. The position accounts for 0.18% of the portfolio, ranked #69.

Shoker Investment Counsel first reported a position in LLY in Q2 2020 and has held it in 13 quarters since. The position peaked at $715K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Shoker Investment Counsel held 665 shares of Eli Lilly worth $612K as of Q1 2026.
  • Shoker Investment Counsel left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.18% of Shoker Investment Counsel's portfolio in Q1 2026, its #69 holding.
  • Shoker Investment Counsel first reported a position in Eli Lilly in Q2 2020 and has held it in 13 quarters since.
  • Shoker Investment Counsel's Eli Lilly position peaked at $715K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Shoker Investment Counsel's 13F filing for Q1 2026, filed 11 May 2026.